Adult-Onset Type 1 Diabetes Elevates Risk of Heart Disease and Mortality, New Research Finds

New research reveals that adult-onset type 1 diabetes significantly increases the risk of cardiovascular disease and death, highlighting the importance of lifestyle modification and improved disease management.
Recent research published in the European Heart Journal highlights that individuals diagnosed with type 1 diabetes during adulthood face a significantly increased risk of cardiovascular disease and overall mortality. The study, led by researchers at Karolinska Institutet in Sweden, emphasizes that adult-onset type 1 diabetes, especially cases diagnosed after age 40, carries serious health implications comparable to early-onset cases.
Using a comprehensive registry-based approach, the study analyzed data from over 10,000 adults diagnosed with type 1 diabetes between 2001 and 2020, comparing their health outcomes with a control group of more than half a million people. Findings revealed that these individuals had higher incidences of cardiovascular conditions, cancer, infections, and increased risk of death from all causes.
Key risk factors identified include smoking, obesity, and poor glycemic control. Interestingly, the study noted that patients diagnosed later in life were less likely to use assistive devices like insulin pumps, which could influence health outcomes. The authors stress that these modifiable factors can markedly improve prognoses if addressed properly.
Lead researcher Yuxia Wei points out that the prognosis of adult-onset type 1 diabetes can be markedly improved by targeting lifestyle factors and optimizing disease management. Senior researcher Sofia Carlsson adds that further research is needed into the disease's risk factors, treatment strategies, and the role of advanced technologies, including insulin pump therapy.
This study underscores the importance of early intervention and lifestyle modifications for individuals diagnosed with type 1 diabetes later in life, advocating for healthcare strategies to reduce the risk of severe complications and improve survival rates.
For more detailed findings, visit source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Role of GLP-1 Receptor Agonists in Managing Obesity
Explore how GLP-1 receptor agonists like Ozempic are transforming obesity treatment in Australia, highlighting research, clinical applications, and future challenges.
Innovative Findings Could Enhance Hemophilia A Treatments
New research identifies structural variations in factor VIII that contribute to treatment resistance in hemophilia A, paving the way for more effective therapies.
HHS Discontinues CDC Staff Responsible for Ensuring Safe Birth Control for Women with Medical Risks
The HHS has disbanded key CDC staff responsible for creating guidelines that ensure the safe use of contraception for women with underlying health conditions, raising concerns about reproductive health safety and future policy updates.
Innovative Menstrual Hygiene Tech: AI-Enabled Sanitary Pads Detect Health Biomarkers
ETH Zurich researchers have developed MenstruAI, a smart sanitary pad using AI and test strips to detect health biomarkers in menstrual blood, offering a simple and non-invasive way to monitor health and identify potential diseases early.